A detailed history of Mesirow Institutional Investment Management, Inc. transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Mesirow Institutional Investment Management, Inc. holds 1,755,455 shares of ADMA stock, worth $33.5 Million. This represents 1.79% of its overall portfolio holdings.

Number of Shares
1,755,455
Previous 2,609,282 32.72%
Holding current value
$33.5 Million
Previous $17.2 Million 13.96%
% of portfolio
1.79%
Previous 1.6%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 02, 2024

SELL
$5.98 - $11.18 $5.11 Million - $9.55 Million
-853,827 Reduced 32.72%
1,755,455 $19.6 Million
Q1 2024

May 06, 2024

BUY
$4.4 - $6.74 $11.5 Million - $17.6 Million
2,609,282 New
2,609,282 $17.2 Million

Others Institutions Holding ADMA

About ADMA BIOLOGICS, INC.


  • Ticker ADMA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 196,356,992
  • Market Cap $3.75B
  • Description
  • ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...
More about ADMA
Track This Portfolio

Track Mesirow Institutional Investment Management, Inc. Portfolio

Follow Mesirow Institutional Investment Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mesirow Institutional Investment Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Mesirow Institutional Investment Management, Inc. with notifications on news.